NFKB1 and melanoma: Giles et al. [27] also came to the conclusion that miR-7-5p had the ability to inactivate the NF-κB pathway to suppress the growth and metastasis of melanoma, which suggests that miR-7-5p has the potential to be a treatment target for melanoma.